Drug-drug interactions of direct oral anticoagulants (DOACs): from pharmacological to clinical practice
N Ferri, E Colombo, M Tenconi, L Baldessin, A Corsini - Pharmaceutics, 2022 - mdpi.com
The direct oral anticoagulants (DOACs), dabigatran, rivaroxaban, apixaban, and edoxaban,
are becoming the most commonly prescribed drugs for preventing ischemic stroke in …
are becoming the most commonly prescribed drugs for preventing ischemic stroke in …
Heart failure following anti-inflammatory medications in patients with type 2 diabetes mellitus
A Holt, JE Strange, N Nouhravesh, SK Nielsen… - Journal of the American …, 2023 - jacc.org
Background Fluid retention and endothelial dysfunction have been related to use of
nonsteroidal anti-inflammatory drugs (NSAIDs), and type 2 diabetes mellitus (T2DM) has …
nonsteroidal anti-inflammatory drugs (NSAIDs), and type 2 diabetes mellitus (T2DM) has …
Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk
A Cid, ME Smetana, C Hebert, K Coe… - … : The Journal of …, 2022 - Wiley Online Library
Abstract Study Objective The aim of this study was to evaluate the effect on bleeding risk
when fluconazole is administered concomitantly with direct oral anticoagulants (DOACs) …
when fluconazole is administered concomitantly with direct oral anticoagulants (DOACs) …
Critical considerations for co-administering rivaroxaban and vonoprazan: unveiling potential pharmacokinetic interactions
X Xu, Z Zhang, X Zhang, J Luo, Y Zhong, L Jin… - Chemico-Biological …, 2024 - Elsevier
To study the effects of metabolic enzyme activity inhibition and genetic polymorphisms on
the pharmacokinetics and pharmacodynamics of rivaroxaban, we established an in vitro …
the pharmacokinetics and pharmacodynamics of rivaroxaban, we established an in vitro …
Managing the Drug-Drug Interaction With Apixaban and Primidone: A Case Report
MM Manis, K Petersen, MZ Roberts… - Hospital …, 2023 - journals.sagepub.com
The management of the drug-drug interaction (DDI) between primidone, a moderate to
strong cytochrome P-450 (CYP) 3A4 inducer, and apixaban, a direct oral anticoagulant …
strong cytochrome P-450 (CYP) 3A4 inducer, and apixaban, a direct oral anticoagulant …
Dose-adjusted direct oral anticoagulants (DOACs) in patients with acute leukemia: experience of a tertiary cancer care center
SA Bruner, AJ DiPippo, CR Rausch - Leukemia & Lymphoma, 2024 - Taylor & Francis
We conducted a single-center, retrospective, cohort study of 50 adult patients (≥ 18 years
old) with acute leukemia or high-risk myelodysplastic syndrome (MdS) on apixaban …
old) with acute leukemia or high-risk myelodysplastic syndrome (MdS) on apixaban …
Pharmacological options for Candida albicans Endocarditis at the roadblock with irrecoverable prosthetics and drug interactions: a case report and review of literature
S Sahra, A Javed, A Jahangir, SK Thind - BMC Infectious Diseases, 2023 - Springer
Background Candidemia is the fourth most common nosocomial bloodstream infection.
Endocarditis from candidemia is a rare but possibly fatal complication. The efficacy of …
Endocarditis from candidemia is a rare but possibly fatal complication. The efficacy of …
Interações medicamentosa mediadas pela CYP 450 em pacientes críticos: ênfase em antifúngicos triazólicos
SS de Moraes, LRA Manaças… - Revista Eletrônica Acervo …, 2023 - acervomais.com.br
objetivo: Fornecer informações sobre as principais alterações fisiológicas que podem
influenciar as propriedades farmacológicas em pacientes críticos e das interações …
influenciar as propriedades farmacológicas em pacientes críticos e das interações …
Antifúngicos azólicos: utilidade clínica e interações medicamentosas: Azole antifungals: clinical utility and drug interactions
SS de Moraes, LS Felix… - Brazilian Journal of …, 2022 - ojs.brazilianjournals.com.br
No ambiente hospitalar, principalmente em unidades de terapia intensiva, as infecções
fúngicas oportunistas representam um grande desafio a comunidade médica e científica …
fúngicas oportunistas representam um grande desafio a comunidade médica e científica …
Suvremena antikoagulantna terapija
D Čolak - 2023 - repozitorij.mef.unizg.hr
Hemostaza je fiziološki proces zaustavljanja krvarenja. U slučaju prokoagulantno narušene
hemostatske ravnoteže nastaje tromboza. Antikoagulantni lijekovi omogućuju prevenciju i …
hemostatske ravnoteže nastaje tromboza. Antikoagulantni lijekovi omogućuju prevenciju i …